Crowdonomics
WatchlistPortfolio
Hypha Labs, Inc.

Reg A+ · Equity · Feb 2025

ClosedReg A+Equity
via DealMaker · last checked Aug 16, 2026
Raised
$0 / $12.2M max
0% of ceiling
Investors
—
—
Estimated pre-money
$25.7M
—

Financials disclosed in this offering

FY2023 · hover for source
$0
$247K
FY2023
RevenueNet income
Metric
FY2023 audited
Income statement
Revenue
$0
Cost of goods sold
$0
Net income
$246,774
Balance sheet
Cash
$271,006
Accounts receivable
$0
Total assets
$1,409,464
Short-term debt
$665,000
Long-term debt
$0
Total liabilities
$3,280,970
Other
Headcount
7

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

3 amendments
  1. Jun 26, 2025
    Amended during SEC review — offering terms unchanged
    Form 1-A/A on EDGAR ↗
  2. Jun 16, 2025
    Amended during SEC review — offering terms unchanged
    Form 1-A/A on EDGAR ↗
  3. Apr 21, 2025
    Amended during SEC review — offering terms unchanged
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Est. pre-money$25.7M
Price / share$0.20
Shares offered110,000,000

Estimated, not stated: $0.20 × 128,429,367 securities outstanding.

Offering details

Target—
Max$12,200,000
Min investment—
OpenedFeb 24, 2025
Deadline—
ClosedApr 17, 2025
Days active52

Links & provenance

SEC filing
Source: SEC EDGAR
0001493152-25-008006
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.